Authors: HOPPE B HESSE A BROMME S RIETSCHEL E MICHALK D

Citation: B. Hoppe et al., URINARY-EXCRETION SUBSTANCES IN PATIENTS WITH CYSTIC-FIBROSIS - RISK OF UROLITHIASIS, Pediatric nephrology, 12(4), 1998, pp. 275-279

Authors: SIDHU H HOPPE B HESSE A TENBROCK K BROMME S RIETSCHEL E PECK AB

Citation: H. Sidhu et al., ABSENCE OF OXALOBACTER-FORMIGENES IN CYSTIC-FIBROSIS PATIENTS - A RISK FACTOR FOR HYPEROXALURIA, Lancet, 352(9133), 1998, pp. 1026-1029

Authors: RICHARD DA NOUSIAARVANITAKIS S SOLLICH V HAMPEL BJ SOMMERAUER B SCHAAD UB SARDET A BROMME S KLODITZ E LIETZ T SCHILLE R POSSELT HG NOLL S ZIMMERMANN T BARMEIERWASMUTH H WAHN U WEBER A MAGDORF K WACKER F TROGER J LYLE M SCHMIDT A PREUSS I KRASEMANN C NIKOLAIDIS P PEONIDES A SKALIDOPOULOS S SOTIRIADIS G GYURKOVITS K BOLBAS K RIVLIN J MASTELLA G CIPOLLI M TROGU P BARRETO C LARA E EGNER J HAUPTMANN M WEDGWOOD J

Citation: Da. Richard et al., ORAL CIPROFLOXACIN VS INTRAVENOUS CEFTAZIDIME PLUS TOBRAMYCIN IN PEDIATRIC CYSTIC-FIBROSIS PATIENTS - COMPARISON OF ANTIPSEUDOMONAS EFFICACY AND ASSESSMENT OF SAFETY WITH ULTRASONOGRAPHY AND MAGNETIC-RESONANCE-IMAGING, The Pediatric infectious disease journal, 16(6), 1997, pp. 572-578